Revenue Recognition. For the fiscal quarter beginning April 1 and ending June 30, 2000, and without regard to the Effective Date of this Agreement, InterMune shall be entitled to book and recognize Actimmune Net Sales for sales of all Actimmune Units and the Actimmune Gross Margin. Effective July 1, 2000, InterMune shall be entitled to book and recognize all revenues, sales, margins, etc. from the sales of Actimmune.
Appears in 4 contracts
Samples: Revenue Adjustment Agreement (Horizon Pharma PLC), Revenue Adjustment Agreement (Vidara Therapeutics International LTD), Revenue Adjustment Agreement (Intermune Pharmaceuticals Inc)